Alberto Sanchez-Fueyo Selected Research

Alberto Sanchez-Fueyo Research Topics

6	Liver Diseases (Liver Disease) 09/2023 - 04/2015
5	Fibrosis (Cirrhosis) 01/2022 - 01/2017
3	Inflammation (Inflammations) 01/2021 - 01/2015
2	Liver Failure 08/2023 - 01/2019
1	Acute-On-Chronic Liver Failure 08/2023
1	Acute Liver Failure (Fulminant Hepatic Failure) 08/2023
1	Sepsis (Septicemia) 08/2023
1	COVID-19 02/2023
1	Necrosis 01/2022
1	Fatty Liver 01/2022
1	End Stage Liver Disease 10/2021
1	Autoimmune Hepatitis 10/2018
1	Autoimmune Diseases (Autoimmune Disease) 08/2017
1	Chronic Hepatitis C 01/2017
1	Iron Deficiencies 01/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2014
1	Hepatitis B 07/2002

2	CytokinesIBA 01/2022 - 01/2015
1	AntioxidantsIBA 09/2023
1	MicroRNAs (MicroRNA)IBA 08/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Alanine Transaminase (SGPT)IBA 12/2018
1	Interleukin-2 (IL2)IBA 10/2018
1	InterferonsIBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2017
1	IronIBA 01/2015
1	Concanavalin AIBA 01/2015

8	Liver Transplantation 02/2023 - 07/2002
3	Transplantation 02/2023 - 07/2014
2	Therapeutics 01/2022 - 01/2017
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2017